A Comparison of Exhaled Carbon Monoxide Measurements Using the iCOquit Smokerlyzer and Vitalograph Breath CO Monitor vs Carboxyhemoglobin From Venous Samples While Validating a Mobile Research Application

Completed

Conditions studied: Smoking, Cigarette

In brief

The main objective of this study is to determine the accuracy and precision of the iCOquit Smokerlyzer as compared with the gold standard of COHb levels measured in venous plasma samples, as well as assessing its agreement with the Vitalograph BreathCO monitor. Validating the precision and accuracy of the iCOquit Smokerlyzer could establish an additional, less expensive, reliable method for determining smoking status in tobacco research. Additionally, the portability of the device would allow for remote biochemical verification of smoking status, thus enlarging the number of participants that can be included in intervention studies.

Key facts

Study ID

NCT04826549

Run by

Rose Research Center, LLC

People needed

30

Starts

2021-03-22

Expected to finish

2021-10-27

Last updated by the study team

2022-01-13

Who can join

Age: 21 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Has signed the ICF and is able to read and understand the information provided in the ICF.
• Is 21 to 65 years of age (inclusive) at screening.
• No intention of quitting smoking in the next 30 days.
• Willing and able to comply with the requirements of the study.
• Owns a smartphone running iOS or Android with text message and data capabilities compatible with the eResearch app.

You may not qualify if…

• Is unhealthy or cannot participate in the study for any reason (e.g., medical, psychiatric, and/or social reason) as judged by the Investigators or designated medical staff based on all available assessments from the screening period (e.g., vital signs, physical examination, concomitant medications and medical history).
• PHQ-9 score greater than 9, or a score greater than 0 on item #9 ("Thoughts you would be better off dead, or of hurting yourself in some way") at screening.
• Body mass index (BMI) greater than 40.0 kg/m2
• Use of any of these products in the past 30 days:
• Illegal drugs (or if the urine drug screen is positive for cocaine, THC, amphetamines, methamphetamines, or opiates),
• Experimental (investigational) drugs that are unknown to participant,
• Chronic opioid use.
• Pregnant or nursing (by self-report) or positive urine pregnancy test.
• Participant enrollment numbers met.

Where it is running

• Rose Research Center — Charlotte, North Carolina, United States
• Rose Research Center — Raleigh, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.